Search Results - "Brinkmann, Berit J."

Processing human lymph node samples for single-cell assays by Roider, Tobias, Brinkmann, Berit J., Dietrich, Sascha

“…Most non-Hodgkin's lymphomas grow exclusively in the lymph node compartment protected by the tumor microenvironment. To better understand the cellular…”
Get full text

CD20-bispecific antibodies improve response to CD19-CAR T cells in lymphoma in vitro and CLL in vivo models by Brinkmann, Berit J., Floerchinger, Alessia, Schniederjohann, Christina, Roider, Tobias, Coelho, Mariana, Mack, Norman, Bruch, Peter-Martin, Liebers, Nora, Dötsch, Sarah, Busch, Dirk H., Schmitt, Michael, Neumann, Frank, Roessner, Philipp M., Seiffert, Martina, Dietrich, Sascha

“…•CD20/CD3 bispecific antibody enhances the efficacy of CD19–directed CAR T cells.•Combination treatment improved survival in the Eμ-TCL-1 mouse model. [Display…”
Get full text

Multimodal and spatially resolved profiling identifies distinct patterns of T cell infiltration in nodal B cell lymphoma entities by Roider, Tobias, Baertsch, Marc A., Fitzgerald, Donnacha, Vöhringer, Harald, Brinkmann, Berit J., Czernilofsky, Felix, Knoll, Mareike, Llaó-Cid, Laura, Mathioudaki, Anna, Faßbender, Bianca, Herbon, Maxime, Lautwein, Tobias, Bruch, Peter-Martin, Liebers, Nora, Schürch, Christian M., Passerini, Verena, Seifert, Marc, Brobeil, Alexander, Mechtersheimer, Gunhild, Müller-Tidow, Carsten, Weigert, Oliver, Seiffert, Martina, Nolan, Garry P., Huber, Wolfgang, Dietrich, Sascha

“…The redirection of T cells has emerged as an attractive therapeutic principle in B cell non-Hodgkin lymphoma (B-NHL). However, a detailed characterization of…”
Get full text

An autologous culture model of nodal B-cell lymphoma identifies ex vivo determinants of response to bispecific antibodies by Roider, Tobias, Brinkmann, Berit J., Kim, Vladislav, Knoll, Mareike, Kolb, Carolin, Roessner, Philipp M., Bordas, Marie, Dreger, Peter, Müller-Tidow, Carsten, Huber, Wolfgang, Seiffert, Martina, Dietrich, Sascha

“…Bispecific antibodies (BsAbs) can induce long-term responses in patients with refractory and relapsed B-cell lymphoma. Nevertheless, response rates across…”
Get full text

Proteogenomics refines the molecular classification of chronic lymphocytic leukemia by Herbst, Sophie A., Vesterlund, Mattias, Helmboldt, Alexander J., Jafari, Rozbeh, Siavelis, Ioannis, Stahl, Matthias, Schitter, Eva C., Liebers, Nora, Brinkmann, Berit J., Czernilofsky, Felix, Roider, Tobias, Bruch, Peter-Martin, Iskar, Murat, Kittai, Adam, Huang, Ying, Lu, Junyan, Richter, Sarah, Mermelekas, Georgios, Umer, Husen Muhammad, Knoll, Mareike, Kolb, Carolin, Lenze, Angela, Cao, Xiaofang, Österholm, Cecilia, Wahnschaffe, Linus, Herling, Carmen, Scheinost, Sebastian, Ganzinger, Matthias, Mansouri, Larry, Kriegsmann, Katharina, Kriegsmann, Mark, Anders, Simon, Zapatka, Marc, Del Poeta, Giovanni, Zucchetto, Antonella, Bomben, Riccardo, Gattei, Valter, Dreger, Peter, Woyach, Jennifer, Herling, Marco, Müller-Tidow, Carsten, Rosenquist, Richard, Stilgenbauer, Stephan, Zenz, Thorsten, Huber, Wolfgang, Tausch, Eugen, Lehtiö, Janne, Dietrich, Sascha

“…Cancer heterogeneity at the proteome level may explain differences in therapy response and prognosis beyond the currently established genomic and…”
Get full text